Skip to main content
logo
Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
27.26
-0.40 (-1.45%)
Aug 31, 2026, 3:04 PM CST

Huadong Medicine Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
3,4603,4143,5122,8392,4992,302
Depreciation & Amortization
1,0711,012855.03809.56705.55591.56
Other Amortization
37.6527.599.739.696.655.96
Loss (Gain) From Sale of Assets
-9.89-2.265.46-4.32-8.260.03
Asset Writedown & Restructuring Costs
84.4181.4325.195.14-22.68.02
Loss (Gain) From Sale of Investments
12.1775.9282.8202.15115.6252.91
Provision & Write-off of Bad Debts
81.43136.91112.1825.7668.6941.69
Other Operating Activities
59.3483.2487.18121.32137.61132.51
Change in Accounts Receivable
-518.36-673.32-1,980-968.97-2,095-775.57
Change in Inventory
-124.22-828.39-498.85213.85-491.5218.09
Change in Accounts Payable
302.931,0541,566685.551,450770.58
Change in Other Net Operating Assets
-2.120.5220.9843.017.24-
Operating Cash Flow
4,2884,2463,7493,9292,3823,170
Operating Cash Flow Growth
9.10%13.25%-4.59%64.96%-24.86%-7.08%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-1,505-1,574-1,728-1,607-1,193-819.1
Sale of Property, Plant & Equipment
15.0621.119.7610.8515.4379.16
Cash Acquisitions
---620.24-134.06-415.09-819.6
Divestitures
------113.37
Investment in Securities
-191.11-186.88112.84-115.24-948.91-357.5
Other Investing Activities
40.0270.4645.2394.52106.243.72
Investing Cash Flow
-1,641-1,670-2,170-1,751-2,436-1,987

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-4,1355,2514,8764,9752,259
Total Debt Issued
3,9874,1355,2514,8764,9752,259
Long-Term Debt Repaid
--5,165-4,263-5,729-4,653-2,405
Total Debt Repaid
-4,585-5,165-4,263-5,729-4,653-2,405
Net Debt Issued (Repaid)
-598.65-1,030987.92-852.43322.13-146.03
Issuance of Common Stock
---10.63104.65-
Repurchase of Common Stock
-9.19-13.81-4.13---
Common Dividends Paid
-1,676-1,692-1,702-594.21-576.49-460.11
Other Financing Activities
10.69-86.53-31.2842.6650.01-161.31
Financing Cash Flow
-2,273-2,822-749.66-1,393-99.71-767.45

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
107.79-7.59-475.95-9.777.11
Net Cash Flow
482.35-254.23781.99791.25-163.23422.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
2,7842,6712,0212,3231,1892,351
Free Cash Flow Growth
34.32%32.17%-12.98%95.40%-49.44%21.26%
Free Cash Flow Margin
6.33%6.13%4.82%5.72%3.15%6.80%
Free Cash Flow Per Share
1.591.521.151.330.681.34
Levered Free Cash Flow
2,5922,0511,2551,862604.482,104
Unlevered Free Cash Flow
2,6312,1041,3151,934679.512,147

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
----0.620.95
Cash Income Tax Paid
2,9172,9182,5632,5523,0181,539
Change in Working Capital
-508.6-584-940.75-78.95-1,12135.45